Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth cause of mortality and morbility in the developed world. Patients with COPD experience a progressive deterioration of health-related quality of life (HRQOL). A new model of severity classification, the body mass index, bronchial obstruction, dyspnoea, exercise (BODE) index, has recently been proposed. Objective: To evaluate the relationship between HRQOL and the BODE index, and the predictive ability of BODE on HRQOL measurements. Methods: Two HRQOL questionnaires were administered, namely the Nottingham Health Profile (NHP) and St George's Respiratory Questionnaire (SGRQ), in a sample of 67 patients with severe COPD. Results: Pearsonś correlation coefficient analysis shows a positive correlation between the BODE index and the total scores of the specific (P Ͻ 0.001), and general HRQOL (P Ͻ 0.001); the analysis shows a significant correlation between the BODE index and the subscales of symptoms, activity and impact of SGRQ (P Ͻ 0.001) and the subscales energy and physical mobility of the NHP (P Ͻ 0.001). The regression analysis shows that the BODE index is a significant predictor of HRQOL, explaining 46,1% of the total score of the SGRQ (P Ͻ 0.001) and 14.8% of the total score of the NHP (P Ͻ 0.001).
Introduction
Chronic obstructive pulmonary disease (COPD) is a prevalent disease characterized by poorly reversible airflow limitation, and it is a condition associated with a high level of disability. As the goals of COPD treatment are mainly palliative (reducing symptoms, increasing functions), the evaluation of health status in patients with COPD has been traditionally on the basis of objective methods of observation or medical intervention (clinical examination, lung function tests, etc.). 1, 2 Nevertheless, the available evidence suggests that there is poor correlation between self-perceived measurements, referred by patients and data provided by lung function tests while they were on pharmacological treatments or after respiratory rehabilitation programs. 3, 4 As disease progresses, patients with COPD experience increasing deterioration of their Health-Related Quality of Life (HRQOL), with greater impairment in their ability to work and declining participation in social and physical activities. 5, 6 For that reason, over the past decade, more research on the development and validation of questionnaires has been undertaken to quantify the impact of their disease on daily life and on the well-being from the perspective of COPD patients. 7 Patients with COPD have systemic manifestations that are not accounted for by lung function tests. Recently, a new multidimensional grading system, the body mass index, bronchial obstruction, dyspnoea, exercise (BODE) index, was proposed to provide useful prognostic information of COPD patients. This multidimensional grading system incorporates four parameters: assessment of symptoms, nutritional state, exercise capacity and lung function [forced expiratory volume in the first second (FEV1)], all aimed to include both respiratory and systemic manifestations ORIGINAL PAPER Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity of the BODE index of COPD. BODE was reported to be better than FEV 1 alone to predict the risk of death in COPD. 8 Recently, Cote and Celli 9 have demonstrated the utility of the BODE index in the evaluation of pulmonary rehabilitation programs, and Ong et al. 10 also reported the capacity of BODE to predict hospitalizations in COPD patients.
The objective of the present study is to evaluate the existence of associations between HRQOL and the BODE index; also, to evaluate the predictive value of the BODE index on general and specific HRQOL questionnaires, in a sample of patients with severe COPD.
Methods

Study design
A cross-sectional sample of patients with COPD was selected and examined extensively by physiological lung function tests and a battery of specific and generic HRQOL measures. All patients were included in the Continued attention to the chronic respiratory patient program (RESC) at the Department of Respiratory Medicine of Joan March Hospital, Spain. The 67 consecutive outpatients with a diagnosis of COPD who agreed to participate in the RESC program and met the inclusion criteria were included in our study.
Patients
The subjects of this study were consecutive patients with a diagnosis of COPD on the basis of medical history, current symptoms and available pulmonary function tests as per the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 11 from the Joan March Hospital in Bunyola (Mallorca, Spain). Inclusion criteria were: COPD with an FEV 1 Ͻ 80% of predicted and age 50-90 years. All participants were smokers or former smokers with a smoking history of 10 pack-years or more. Exclusion criteria were other disabling or severe disease and/or coexistence of other causes of impaired pulmonary function. Patients with a history of indicative asthma were excluded. None of them were in acute COPD exacerbation at the time of investigation.
Measures
Clinical data and lung function tests
All participants were administered a structured clinical interview to obtain the following clinical, social and demographic parameters: age, gender, weight, height, diagnosis of COPD, number of hospitalizations in the last year and presence of comorbidities (Charlson) . 12 Lung function measurement included: spirometric parameters (FEV1, FVC) to determine the COPD severity (absolute and reference values), according to the methods described in the American Thoracic Society/European Respiratory Society, 2005. 13 
Exercise performance and breathlessness
The 6-minute walking test (6WT) a one-trial protocol was conducted in this investigation. Patients were instructed to walk as far as possible for six minutes, taking rest periods if necessary. Before each test, the patient's resting heart rate, blood pressure and arterial oxygen saturation level were monitored at rest in a sitting position. These measurements were taken primarily for patient monitoring and safety purposes, and were not formally collected or analysed. The total distance walked was measured to the nearest meter and recorded. All patients were tested by the same technician and after one practice test. 14 The Medical Research Council (MRC) scale: this dyspnoea scale has been used for many years for grading breathlessness on daily activities. This scale measures perceived respiratory disability. Patients were asked about their perceived breathlessness and were then classified into the MRC five dyspnoea grades (1 minimal to 5 maximum) according to how they perceived their disability. 15 
Outcome measures
The Nottingham Health Profile (NHP): the NHP was developed to be used in epidemiological studies of health and disease. It consists of two parts. Part I contains 38 yes/no items in six dimensions: pain, physical mobility, emotional reactions, energy, social isolation and sleep. Part II contains seven general yes/no questions on daily living problems. The two parts may be used independently, and part II is not analysed in this study. The NHP questionnaire has an adapted and validated Spanish version, used in our study. 16 The higher the NHP score the lower the general quality of life.
The St George's Respiratory Questionnaire (SGRQ) is a standardized self-administered airways disease-specific questionnaire developed by Jones. 7 This questionnaire has an adapted and validated Spanish version used in our study. 17 It contains 50 items divided into three subscales: symptoms (eight items), including several respiratory symptoms, their frequency and severity; activity (16 items), on activities that cause or are limited by breathlessness; and impact (26 items) which covers a wide range of aspects related with social functioning and psychological disturbances resulting from airways disease. The higher the SGRQ score the lower the general quality of life.
Design
All patients underwent the clinical examination, lung functional tests and questionnaires on the same day. Within that session, the clinical, social and demographic data were collected; then, the lung function and the 6 WTs were conducted. Brief instructions from the administrator, an appointed psychologist, were given to all subjects before completing the questionnaires. All questionnaires were completed in the same order: first the HRQOL questionnaires (NHP and SGRQ), then the dyspnoea scale (MRC), and finally the body mass index and the BODE index were calculated.
Statistical analysis
Univariate, descriptive statistics were computed for all variables. All variables had normal distributions. Parametric Pearson correlation coefficient analysis was calculated to study the association between HRQOL and the BODE index. The linear regression method (standard/enter method) was used to identify the factors that were most strongly related with HRQL scores. All variables with a P-value Ͻ 0.05 were entered into the regression model, and changes were considered to be statistically significant at the 0.05 level of significance. Data were analysed by means of the statistical program SPSS. 12 for Windows.
Results
Sixty seven patients, who previously had been diagnosed with COPD, were included from the respiratory outpatients clinic at the Joan March Hospital over a period of ten months (May 2004-March 2005). They were 62 men and 5 women, aged 51 to 90 years (mean ϭ 69.7; SD ϭ 8.9) and whose other clinical and baseline characteristics are detailed in Table 1 . The patients were all former or current heavy smokers with disease duration of several years. For calculation of the BODE index we used the empirical model described by Celli et al. The characteristics of baseline BODE index factors are detailed in Table 2 .
Correlation analysis
The Pearson's correlation analysis between the BODE index and HRQOL shows a positive and significant correlation (P Ͻ 0.001), both with the general (NHP) and respiratory specific (SGRQ) questionnaires. Further, a significant association between the BODE index and all SGRQ subscales, symptoms, activity and impacts (P Ͻ 0.001) was observed. This correlation is only seen in two subscales of the general HRQOL questionnaire (NHP) energy and physical mobility. Pearson correlation coefficients for the overall NHP and SGRQ total scores, and the BODE index are given in Table 3 . 
Regression analysis
In a secondary analysis, the predictive validity of the BODE index was explored on both HRQOL questionnaires (SGRQ and NHP) and on all their subscales, obtaining the following results (Table 4) : SGRQ and NHP total scores: results of the regression analysis by the enter method indicated that the model significantly predicts 46.1% (P Ͻ 0.001) of the variance of the total SGRQ score. The model also significantly predicts 14.8% (P Ͻ 0.01) of the variance of the total NHP scores.
When analysing the SGRQ subscales the following results are seen: the subscale impact significantly predicted 42.2% (P Ͻ 0.001) of the variance; additionally, 19.5% (P Ͻ 0.001) of the subscale symptoms and 30.7% (P Ͻ 0.001) of the subscale activity were also predicted.
When analysing the NHP subscales, the equation is also significant, predicting 34.8% (P Ͻ 0.01) of the variance of the subscale physical mobility and 29.3% (P Ͻ 0.01) of the subscale energy.
Our regression analysis suggests that the BODE index is a significant predictor of HRQOL, predicting 46,1% of the variability of the total SGRQ score in patients with COPD. However, the BODE index explains only a 14.8% of the variability of the total NHP score. According to the results of the prediction of the two NHP subscales physical mobility and energy, it appears they practically evaluate the same components as the subscales of activity and impact valued of the SGRQ.
Conclusion
A systematic assessment was conducted aimed to identify factors related with HRQOL and the recent BODE index in COPD patients. Previous results show that, as the severity of COPD increases, a high level of worsening of quality of life is observed in these patients. 18 Actually, the BODE index can provide useful prognostic information on survival, pulmonary rehabilitation outcomes and hospitalization risk, but it was unknown the effect of BODE on quality of life. Our study adds evidence on the association between the BODE index and HRQOL. However, we believe that the main finding of this study is that the BODE staging system, (which includes in addition to FEV1 other physiologic and clinical variables), is shown to be a good predictor of the quality of life in COPD patients, measured with both generic (NHP) and specific (SGRQ) questionnaires of HRQOL. Contrary to previous classification systems based only on FEV1, COPD severity assessed by the BODE index can be more directly related with self-perceived symptoms, difficulties with daily life activities and physical mobility and the level of adaptation to a chronic disease.
However, other generic aspects of patients quality of life analysed by our study such as sleep, pain, social isolation or emotional well-being, will not change according to the severity indicated by the BODE index. These results are pointing to the results obtained by Harper 19 supporting the validity of specific HRQOL instruments like the SGRQ, to be more sensitive to changes than the general questionnaires. In our sample, factors like sleep, pain or social isolation could be less relevant than activities of daily living or subjective dyspnoea perception, possibly because of the severe nature of this sample of patients.
The application of the BODE index as a multidimensional assesment produces a broader glimpse about the reality of COPD patients lives, incorporating a subjective dyspnoea scale MRC additionally to the tests of lung function and exercise capacity. Quality of life, as a measurement of disease, enlarges and complements the clinical staging of COPD patients, adding data about level of psychosocial adaptation and wellbeing, particularly in the severe stages. 20 Several limitations of this study that the authors would like to acknowledge are that a relatively small number of patients were evaluated, and that the number of patients required to detect a significant difference in the predictive power of the BODE index has not been determined. In addition we acknowledge that all participants had severe COPD, and our findings may be not generalized to other levels of severity. Finally the assessment of physiological and psychosocial variables, such as the BODE index and quality of life, allows us to elaborate a more real vision of patients with COPD, therefore, providing us with new sources of information about the systemic manifestations of COPD. 21 
